These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 21256577)
1. Utility of a modality combining FISH and cytology in upper tract urothelial carcinoma detection in voided urine samples of Chinese patients. Xu C; Zeng Q; Hou J; Gao L; Zhang Z; Xu W; Yang B; Sun Y Urology; 2011 Mar; 77(3):636-41. PubMed ID: 21256577 [TBL] [Abstract][Full Text] [Related]
3. Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples. Reynolds JP; Voss JS; Kipp BR; Karnes RJ; Nassar A; Clayton AC; Henry MR; Sebo TJ; Zhang J; Halling KC Cancer Cytopathol; 2014 Jun; 122(6):459-67. PubMed ID: 24604675 [TBL] [Abstract][Full Text] [Related]
4. Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Marín-Aguilera M; Mengual L; Ribal MJ; Musquera M; Ars E; Villavicencio H; Algaba F; Alcaraz A Eur Urol; 2007 Feb; 51(2):409-15; discussion 415. PubMed ID: 17010508 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634 [TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology. Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689 [TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date. Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126 [TBL] [Abstract][Full Text] [Related]
8. Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance. Johannes JR; Nelson E; Bibbo M; Bagley DH J Urol; 2010 Sep; 184(3):879-82. PubMed ID: 20643443 [TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510 [TBL] [Abstract][Full Text] [Related]
10. Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma. Todenhöfer T; Hennenlotter J; Esser M; Mohrhardt S; Tews V; Aufderklamm S; Gakis G; Kuehs U; Stenzl A; Schwentner C Cancer Cytopathol; 2013 May; 121(5):252-60. PubMed ID: 23172833 [TBL] [Abstract][Full Text] [Related]
11. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727 [TBL] [Abstract][Full Text] [Related]
12. Urine cytology and primary carcinoma of the renal pelvis and ureter. Cullen TH; Popham RR; Voss HJ Aust N Z J Surg; 1972 Feb; 41(3):230-6. PubMed ID: 4501630 [No Abstract] [Full Text] [Related]
13. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder]. Asali MG; Kaneti J; Manor E Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439 [TBL] [Abstract][Full Text] [Related]
14. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology. Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263 [TBL] [Abstract][Full Text] [Related]
15. Distinguishing urothelial carcinoma in the upper urinary tract from benign diseases with hematuria using FISH. Wang J; Wu J; Peng L; Tu P; Li W; Liu L; Cheng W; Wang X; Zhou S; Shi S; Ma H; Lu G; Zhou X Acta Cytol; 2012; 56(5):533-8. PubMed ID: 23075895 [TBL] [Abstract][Full Text] [Related]
16. [Cytologic diagnostic value of voided urine in 60 cases of primary transitional cell carcinoma of the renal pelvis and ureter]. Xia TL Zhonghua Wai Ke Za Zhi; 1989 Dec; 27(12):753-5, 782. PubMed ID: 2636116 [TBL] [Abstract][Full Text] [Related]
17. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization]. Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751 [TBL] [Abstract][Full Text] [Related]
19. Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients. Chuang KL; Chuang HC; Ng KF; Chang YH; Wu CT; Chuang CK; Liao SK; Pang ST BJU Int; 2010 May; 105(10):1413-6. PubMed ID: 19818076 [TBL] [Abstract][Full Text] [Related]
20. [Clinical utility of fluorescence in situ hybridization improves the sensitivity in the diagnosis of upper urinary tract urothelial carcinoma]. Mu DW; Zhou LQ; Ding Y; He ZS; Wang Y; He Q; Yang XY Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):381-5. PubMed ID: 20721247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]